I've rebutted most of the negative prognostications

New Post Public Reply Private Reply Replies (0) Message Board

May 16, 2019 at 4:15 AM 191

I've rebutted most of the negative prognostications about zn in previous posts at length

ZN pays as it goes - doesnt get into long term debt-only such long term debt is bonds which are convertible into common stock and thus ultimately wouldnt cost zn much more than fees

much of the hullabaloo re russell index is irrelevant- zn got by for 18 years without being on such- and russell index investors have had 9 months to get out since pps 1st fell below one dollar ca sept 25-27- zn is a spec investment for them and will remain a spec investment for them

most co's like zn apply for another 180 day extension to bring pps to one dollar by building shareholder value-which extensions are regularly granted if the applicant has any reasonable plans-exchanges dont like to lose the 150k in fees /year

if at the end of the 2nd 180 days jan 8,2020 pps is not going to otherwise be over one dollar zn can r/s to stay on the nasdaq-they've signaled their intention in a filing i posted to transfer to another level of the nasdaq during the 2nd 180 days and have not given any indication they would r/s

they/ve never been investigated before and said it was due -though the cause was a complaint by an apparent shorting cartel or entities associated w such who apparently dont politically agree w zn's purposes- sec has not indicated any wrongdoing

price /book of 10 is not unusual for a non-revenue company
price/book and pps for non-revenue co's depends on potential going forward
zn was ca the 5 fastest growth co on nasdaq last june- and if they discover a commercial reservoir they may again be one of the fastest growing- thats one of the reasons they are a spec co invested in by funds looking for spec investments(bc non spec investments usually have small % returns)

and if they discover a commercial field their license would be converted to a 30 yr lease renewable for another 20 years

there is increased activity around zn's license-e.g. delek- which owns 45% of leviathon bought 70% of the license adjacent to zn on the west=
probably figuring the offshore strata may continue under onshore israel- such offshore strata is 5000 to 7000 meters deep- zn's oil shows were near the td bottom at ca 5000 meters w evidence of a petroleum system-
we have no evidence of a delek etc deal but if delek invested in zn's license in some form of deal that would speed things up

if a commercial field is found during the survey this year a new well[possibly from the same pad as the exploratory well(since the 3d survey will surround such well and horizontal drilling can easily extend a few miles now)could be drilled next year,if not sooner if delek etc participated.

in spec co's with no revenue it is not unusual to have price/book ratios of 50-fairly common from what i've seen-and i've seen as high as 200

zn had close to 40m assets til write off due to the noncommercial exploratory well-and if such well aids in discovery of a commercial field due to the 3d survey of 60 square km around the well what then?

they have an experienced C level team w main players having over 30 years experience in oil and gas
and the 3d survey specialist they brought over from viking has 26-28 years of experience/surveys and has supervised as much as 6 wells or surveys and 500 people at a time

the exec compensation committee displayed info showing zn execs were underpaid cf to similar competition and much of their pay is is in stock options to conserve cash-and such options are valued at either the time the option becomes available or is exercised

-so their pay has been much less than some have advertised- those who say zn pps dropped x% should note that the portion of exec pay attributed to stock is much less ,having lost value like everybody else's stock,especially since a filing indicated execs had an agreement to not sell since ca may 17 2017- weeks before the mj1 well was spudded-and execs no doubt restricted themselves to help avoid harmful speculation
and thus execs have not sold stock since may 2017 -except one ex exec who donated stock to nonprofits etc

ceo dustin unselfishly resigned so zn could save money(filing indicated streamlining) as per his resignation letter so his friend Robert Dunn- a 3d specialist from viking -could be brought in as director of operations -if zn again needs a drilling specialist we may see dustin again

drilling plans will be dictated by the 3d survey

Zion Oil & Gas, Inc. (ZNOG) Stock Research Links

ZNOG Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ARTiSTORY's Strategic Advance in Cultural IP Licensing

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Countries Eye New Investment Paths at CIFIT 2026

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Nocpix Unveils ACE 2 Thermal Riflescope Lineup

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Silk Road Maritime Extends Its Global Reach in 2026

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

PathoSearch: A New Era in Pathology With Visual Search

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

IASLC Boosts Global Thoracic Cancer Collaboration

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Delhi Pushes Innovation Against Dryland Challenges

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...